DocuSign President Sells 14,676 Shares
Key Points
President General Manager liquidated 14,676 shares at a weighted average price of $69.41, representing a transaction value of ~$1.0 million on September 17, 2026.
The sale involved shares equal to 16% of the equity stake held by the insider before the filing.
All shares were held directly, with no indirect holdings reported in the disclosure.
The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, characterizing the activity as a structured liquidity event.
- 10 stocks we like better than Docusign ›
Robert Chatwani, President General Mgr, Growth at Docusign (NASDAQ:DOCU), sold 14,676 shares of common stock on Sept. 17, 2026, according to a recent SEC Form 4 filing.
Transaction summary
| Metric | Value |
|---|---|
| Shares sold | 14,676 |
| Transaction value | ~$1.0 million |
| Post-transaction shares (directly held) | 75,928 |
| Post-transaction value | ~$5.3 million |
Transaction value based on SEC Form 4 weighted average sale price ($69.41); post-transaction value based on Sept. 17, 2026, market close ($70.64).
Key questions
- What was the regulatory framework for this transaction?
The executive executed this sale pursuant to a Rule 10b5-1 plan, a mechanism that allows company insiders to establish predetermined trading schedules for selling shares to satisfy liquidity needs. - How did the execution price compare to the market close on the date of the trade?
The shares were sold at a weighted average price of $69.41, while the stock reached a market close of $70.64 on Sept. 17, 2026. - What is the insider's remaining ownership interest in the company?
Following the disposition, the executive retains a direct position of 75,928 shares, which represents approximately 0.0398% of the company's outstanding equity. - What has been the recent performance context for the stock?
At the time of the transaction on Sept. 17, 2026, the company's one-year total return was -16%.
Company Overview
| Metric | Value |
|---|---|
| Share Price (as of market close 2026-09-22) | $66.76 |
| Market Capitalization | $12.6 billion |
| Revenue (TTM) | $3.4 billion |
| Net Income (TTM) | $329.9 million |
Company Snapshot
- Docusign provides a comprehensive suite of electronic signature and digital agreement management solutions, including core e-signature capabilities, Contract Lifecycle Management (CLM), and agreement workflow automation tools that serve as primary revenue drivers across enterprise and mid-market segments.
- The company operates a subscription-based software-as-a-service (SaaS) business model, generating recurring revenue through tiered licensing arrangements while supplementing core revenue through implementation services and professional consulting engagements.
- Docusign serves a diverse customer base spanning financial services, healthcare, legal, real estate, and technology sectors, with particular penetration among enterprises requiring high-volume agreement processing and compliance-intensive workflows.
Docusign is a global leader in the digital agreement management software market, commanding a substantial installed base of 7,044 employees and generating $3.4 billion in TTM revenue with $330 million in net income.
The company's competitive positioning is anchored in its established market presence, an extensive product ecosystem spanning agreement preparation, execution, and lifecycle management, and deep integrations with enterprise systems.
Docusign's strategic focus on expanding its CLM capabilities and driving platform consolidation positions it to capture incremental wallet share from customers seeking unified digital agreement solutions.
What this transaction means for investors
This sale shouldn't concern investors. It was executed under a Rule 10b5-1 plan, which insiders commonly use to avoid concerns about acting on non-public information. The executive still retains the majority of the stake, worth about $5 million at current share prices.
Importantly, Docusign has reported improving growth this year. In the July-ending fiscal quarter, revenue grew 9.4% year over year. Margins are also expanding, with operating profit surging 80% year over year to $118 million.
Analysts expect earnings to grow at an annualized rate of 22% over the next several years. Assuming the company delivers, that should support the stock's valuation, which is currently modest at 13.7x forward earnings estimates.
Should you buy stock in Docusign right now?
Before you buy stock in Docusign, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Docusign wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $389,154!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,406,303!*
Now, it’s worth noting Stock Advisor’s total average return is 949% — a market-crushing outperformance compared to 214% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of September 23, 2026.
John Ballard has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Docusign. The Motley Fool has a disclosure policy.
